Nevro (NVRO) News Today $4.57 +0.07 (+1.58%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Nevro Corp. (NYSE:NVRO) Shares Sold by Barclays PLCBarclays PLC reduced its stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 59.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 61,496 shares of the medical equipment provider's stock after selling 88,518 shares during the pJanuary 20 at 3:12 AM | marketbeat.comCiti Reaffirms Their Hold Rating on Nevro Corp (NVRO)January 17, 2025 | markets.businessinsider.comRBC Capital Sticks to Their Hold Rating for Nevro Corp (NVRO)January 16, 2025 | markets.businessinsider.comNevro Corp: Balancing Short-Term Gains and Long-Term Uncertainties with a Hold RatingJanuary 14, 2025 | markets.businessinsider.comNevro sees Q4 revenue $105M-$106M, consensus $100.08MJanuary 14, 2025 | markets.businessinsider.comNevro sees FY24 revenue ~$408M-$409M, consensus $403.14MJanuary 14, 2025 | markets.businessinsider.comNevro Corp.: Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue ResultsJanuary 13, 2025 | finanznachrichten.deNevro Shares Rise 16% After 4Q, 2024 Revenue GuidanceJanuary 13, 2025 | marketwatch.comNevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue ResultsJanuary 13, 2025 | prnewswire.comNevro Corp. (NYSE:NVRO) Receives Consensus Rating of "Reduce" from AnalystsJanuary 12, 2025 | americanbankingnews.comNevro Corp. (NYSE:NVRO) Given Average Recommendation of "Reduce" by AnalystsNevro Corp. (NYSE:NVRO - Get Free Report) has earned an average rating of "Reduce" from the thirteen research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation and ten have assigned a hold recommendation to thJanuary 12, 2025 | marketbeat.comState Street Corp Sells 241,495 Shares of Nevro Corp. (NYSE:NVRO)State Street Corp cut its holdings in Nevro Corp. (NYSE:NVRO - Free Report) by 24.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 752,631 shares of the medical equipment provider's stock after selling 241,495December 30, 2024 | marketbeat.comRBC Capital Remains a Hold on Nevro Corp (NVRO)December 20, 2024 | markets.businessinsider.comTruist Financial Has Lowered Expectations for Nevro (NYSE:NVRO) Stock PriceTruist Financial cut their price target on shares of Nevro from $7.00 to $4.70 and set a "hold" rating on the stock in a report on Wednesday.December 18, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Receives Consensus Recommendation of "Reduce" from AnalystsShares of Nevro Corp. (NYSE:NVRO - Get Free Report) have received an average rating of "Reduce" from the fourteen ratings firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation and eleven have assigned a hold recommendationDecember 18, 2024 | marketbeat.comNevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08December 17, 2024 | prnewswire.comNevro Corp (NVRO) Receives a Hold from Wells FargoDecember 11, 2024 | markets.businessinsider.comNevro price target lowered to $5 from $6 at CitiDecember 11, 2024 | markets.businessinsider.comZacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEXDecember 11, 2024 | finance.yahoo.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 566,462 Shares of Nevro Corp. (NYSE:NVRO)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Nevro Corp. (NYSE:NVRO - Free Report) by 130.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,000,000 shares ofDecember 11, 2024 | marketbeat.comNevro price target lowered to $4 from $7 at CanaccordDecember 10, 2024 | markets.businessinsider.comJacobs Levy Equity Management Inc. Purchases 246,979 Shares of Nevro Corp. (NYSE:NVRO)Jacobs Levy Equity Management Inc. increased its position in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 50.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 732,717 shares of the medical equipment provider's stock afDecember 7, 2024 | marketbeat.comWestern Standard LLC Takes $5.47 Million Position in Nevro Corp. (NYSE:NVRO)Western Standard LLC purchased a new stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 978,981 shares of the medical equipmeDecember 6, 2024 | marketbeat.comShay Capital LLC Increases Stake in Nevro Corp: A Strategic Move Amidst Financial ChallengesDecember 4, 2024 | gurufocus.comNevro Corp: Hold Rating Amid Market Challenges and Strategic UncertaintyDecember 4, 2024 | markets.businessinsider.comMorgan Stanley Downgrades Nevro (NVRO)December 3, 2024 | msn.comNevro (NYSE:NVRO) Stock Rating Lowered by Morgan StanleyMorgan Stanley cut shares of Nevro from an "equal weight" rating to an "underweight" rating and decreased their target price for the company from $9.00 to $4.00 in a research report on Monday.December 2, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Shares Sold by Fred Alger Management LLCFred Alger Management LLC reduced its stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 99.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,591 shares of the medical equipment provider's stock after selling 1,911December 2, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Shares Bought by Engaged Capital LLCEngaged Capital LLC boosted its holdings in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 29.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,442,956 shares of the medical equipment provider'sNovember 29, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Receives Average Rating of "Reduce" from BrokeragesShares of Nevro Corp. (NYSE:NVRO - Get Free Report) have been given a consensus rating of "Reduce" by the fourteen research firms that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation and eleven have given a hold recommenNovember 23, 2024 | marketbeat.comNevro announces publication of new data on Nevro1 SI Joint Fusion SystemNovember 18, 2024 | markets.businessinsider.comNew Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral ApproachesNovember 18, 2024 | prnewswire.comNevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08November 15, 2024 | prnewswire.comNevro Corp. Reports Strong Q3 2024 Financial PerformanceNovember 15, 2024 | markets.businessinsider.comAnalysts Are Updating Their Nevro Corp. (NYSE:NVRO) Estimates After Its Third-Quarter ResultsNovember 14, 2024 | finance.yahoo.comWhat is William Blair's Forecast for Nevro FY2024 Earnings?Nevro Corp. (NYSE:NVRO - Free Report) - Research analysts at William Blair upped their FY2024 earnings per share (EPS) estimates for Nevro in a research note issued to investors on Tuesday, November 12th. William Blair analyst B. Vazquez now expects that the medical equipment provider will earn (November 14, 2024 | marketbeat.comWilliam Blair Estimates Nevro's FY2026 Earnings (NYSE:NVRO)Nevro Corp. (NYSE:NVRO - Free Report) - Analysts at William Blair issued their FY2026 earnings per share (EPS) estimates for Nevro in a research report issued on Tuesday, November 12th. William Blair analyst B. Vazquez anticipates that the medical equipment provider will post earnings of ($2.46)November 13, 2024 | marketbeat.comOppenheimer Sticks to Its Hold Rating for Nevro Corp (NVRO)November 12, 2024 | markets.businessinsider.comNevro Corp (NVRO) Receives a Sell from Piper SandlerNovember 12, 2024 | markets.businessinsider.comWhy Medical Device Firm Nevro Stock Is Trading Higher On TuesdayNovember 12, 2024 | benzinga.comNevro Corp. (NYSE:NVRO) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comNevro's (NVRO) Market Perform Rating Reiterated at JMP SecuritiesJMP Securities reissued a "market perform" rating on shares of Nevro in a report on Tuesday.November 12, 2024 | marketbeat.comNevro (NYSE:NVRO) Price Target Cut to $7.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group dropped their target price on Nevro from $8.00 to $7.00 and set a "hold" rating on the stock in a research report on Tuesday.November 12, 2024 | marketbeat.comNevro (NYSE:NVRO) Earns "Sector Perform" Rating from Royal Bank of CanadaRoyal Bank of Canada reissued a "sector perform" rating and issued a $7.00 price objective on shares of Nevro in a research report on Tuesday.November 12, 2024 | marketbeat.comPiper Sandler Lowers Nevro (NYSE:NVRO) Price Target to $6.00Piper Sandler decreased their price objective on Nevro from $7.00 to $6.00 and set an "underweight" rating on the stock in a report on Tuesday.November 12, 2024 | marketbeat.comRobert W. Baird Issues Positive Forecast for Nevro (NYSE:NVRO) Stock PriceRobert W. Baird upped their price target on Nevro from $5.00 to $6.00 and gave the stock a "neutral" rating in a research note on Tuesday.November 12, 2024 | marketbeat.comNevro Corp. Shows Resilience Amidst Revenue ChallengesNovember 12, 2024 | markets.businessinsider.comJMP Securities Sticks to Its Hold Rating for Nevro Corp (NVRO)November 12, 2024 | markets.businessinsider.comNevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion GloballyNovember 12, 2024 | prnewswire.comQ3 2024 Nevro Corp Earnings Call TranscriptNovember 12, 2024 | gurufocus.com Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVRO Media Mentions By Week NVRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVRO News Sentiment▼-0.030.48▲Average Medical News Sentiment NVRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVRO Articles This Week▼43▲NVRO Articles Average Week Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OrthoPediatrics News Today Semler Scientific News Today Treace Medical Concepts News Today Nano-X Imaging News Today Delcath Systems News Today CVRx News Today Tactile Systems Technology News Today ClearPoint Neuro News Today ZimVie News Today NeuroPace News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVRO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nevro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVRO Stock Alerts